| Harmonizing neuropsychological assessment for mild neurocognitive disorders in Europe | Alzheimer's & dementia |  | | 2022 | 366 | 552 |
|
| Diagnostic value of amyloid-PET and tau-PET: a head-to-head comparison | European Journal of Nuclear Medicine and Molecular Imaging |  | | 2021 | 353 | 256 |
|
| The validation status of blood biomarkers of amyloid and phospho-tau assessed with the 5-phase development framework for AD biomarkers | European journal of nuclear medicine and molecular imaging |  | | 2021 | 230 | 347 |
|
| 2020 update on the clinical validity of cerebrospinal fluid amyloid, tau, and phospho-tau as biomarkers for Alzheimer's disease in the context of a structured 5-phase development framework | European journal of nuclear medicine and molecular imaging |  | | 2021 | 251 | 352 |
|
| The strategic biomarker roadmap for the validation of Alzheimer's diagnostic biomarkers: methodological update | European Journal of Nuclear Medicine and Molecular Imaging |  | | 2021 | 365 | 337 |
|
| Incremental value of amyloid-PET versus CSF in the diagnosis of Alzheimer's disease | European Journal of Nuclear Medicine and Molecular Imaging |  | | 2020 | 422 | 6 |
|
| The A/T/N model applied through imaging biomarkers in a memory clinic | European Journal of Nuclear Medicine and Molecular Imaging |  | | 2019 | 434 | 6 |
|
| Progress update from the hippocampal subfields group | Alzheimer's & dementia |  | | 2019 | 362 | 354 |
|
| Medial temporal lobe atrophy and posterior atrophy scales normative values | NeuroImage: Clinical |  | | 2019 | 512 | 384 |
|
| Assessment of longitudinal hippocampal atrophy in the first year after ischemic stroke using automatic segmentation techniques | NeuroImage: Clinical |  | | 2019 | 300 | 244 |
|
| A comparison of automated segmentation and manual tracing in estimating hippocampal volume in ischemic stroke and healthy control participants | NeuroImage: Clinical |  | | 2018 | 466 | 455 |
|
| Clinical utility of FDG-PET for the differential diagnosis among the main forms of dementia | European Journal of Nuclear Medicine and Molecular Imaging |  | | 2018 | 480 | 0 |
|
| European Association of Nuclear Medicine and European Academy of Neurology recommendations for the use of brain 18 F-fluorodeoxyglucose positron emission tomography in neurodegenerative cognitive impairment and dementia: Delphi consensus | European Journal of Neurology |  | | 2018 | 399 | 2 |
|
| Clinical utility of FDG-PET in amyotrophic lateral sclerosis and Huntington's disease | European Journal of Nuclear Medicine and Molecular Imaging |  | | 2018 | 466 | 0 |
|
| Assessing FDG-PET diagnostic accuracy studies to develop recommendations for clinical use in dementia | European Journal of Nuclear Medicine and Molecular Imaging |  | | 2018 | 445 | 0 |
|
| Automated assessment of FDG-PET for differential diagnosis in patients with neurodegenerative disorders | European Journal of Nuclear Medicine and Molecular Imaging |  | | 2018 | 377 | 0 |
|
| Clinical utility of FDG PET in Parkinson's disease and atypical parkinsonism associated with dementia | European Journal of Nuclear Medicine and Molecular Imaging |  | | 2018 | 513 | 290 |
|
| Quantitative appraisal of the Amyloid Imaging Taskforce appropriate use criteria for amyloid-PET | Alzheimer's & Dementia |  | | 2018 | 460 | 0 |
|
| Clinical utility of FDG-PET for the clinical diagnosis in MCI | European Journal of Nuclear Medicine and Molecular Imaging |  | | 2018 | 462 | 0 |
|
| Diagnostic utility of 18F-Fluorodeoxyglucose positron emission tomography (FDG-PET) in asymptomatic subjects at increased risk for Alzheimer's disease | European Journal of Nuclear Medicine and Molecular Imaging |  | | 2018 | 465 | 0 |
|
| L'atrophie du lobe temporal mésial détectée par IRM en tant que biomarqueur de la maladie d'Alzheimer | Revue médicale suisse |  | | 2018 | 1,012 | 1,716 |
|
| Abnormalities in functional connectivity in borderline personality disorder: Correlations with metacognition and emotion dysregulation | Psychiatry Research: Neuroimaging |  | | 2018 | 496 | 1 |
|
| Diagnostic utility of FDG-PET in the differential diagnosis between different forms of primary progressive aphasia | European Journal of Nuclear Medicine and Molecular Imaging |  | | 2018 | 446 | 252 |
|
| AMYPAD Diagnostic and Patient Management Study: Rationale and design | Alzheimer's & Dementia |  | | 2018 | 484 | 369 |
|
| The biomarker-based diagnosis of Alzheimer's disease. 1-ethical and societal issues | Neurobiology of aging |  | | 2017 | 532 | 7 |
|
| The biomarker-based diagnosis of Alzheimer's disease. 2-lessons from oncology | Neurobiology of Aging |  | | 2017 | 526 | 2 |
|
| Clinical validity of medial temporal atrophy as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework | Neurobiology of Aging |  | | 2017 | 421 | 0 |
|
| Clinical validity of delayed recall tests as a gateway biomarker for Alzheimer's disease in the context of a structured 5-phase development framework | Neurobiology of Aging |  | | 2017 | 438 | 0 |
|
| Clinical validity of brain fluorodeoxyglucose positron emission tomography as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework | Neurobiology of aging |  | | 2017 | 489 | 1 |
|
| Biomarkers for the diagnosis of Alzheimer's disease in clinical practice: an Italian intersocietal roadmap | Neurobiology of aging |  | | 2017 | 515 | 1 |
|
| Clinical validity of increased cortical uptake of amyloid ligands on PET as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework | Neurobiology of aging |  | | 2017 | 527 | 0 |
|
| Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers | The Lancet Neurology |  | | 2017 | 700 | 7 |
|
| Clinical validity of cerebrospinal fluid Aβ42, tau, and phospho-tau as biomarkers for Alzheimer's disease in the context of a structured 5-phase development framework | Neurobiology of Aging |  | | 2017 | 449 | 0 |
|
| A harmonized segmentation protocol for hippocampal and parahippocampal subregions: Why do we need one and what are the key goals? | Hippocampus |  | | 2017 | 427 | 370 |
|
| Reference standard space hippocampus labels according to the European Alzheimer's Disease Consortium-Alzheimer's Disease Neuroimaging Initiative harmonized protocol: Utility in automated volumetry | Alzheimer's & Dementia |  | | 2017 | 423 | 0 |
|
| Clinical validity of presynaptic dopaminergic imaging with 123I-ioflupane and noradrenergic imaging with 123I-MIBG | Neurobiology of Aging |  | | 2017 | 392 | 0 |
|
| Integrating longitudinal information in hippocampal volume measurements for the early detection of Alzheimer's disease | NeuroImage |  | | 2016 | 715 | 4 |
|
| Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly | Neurobiology of aging |  | | 2016 | 775 | 3 |
|
| Do Beliefs about the Pathogenetic Role of Amyloid Affect the Interpretation of Amyloid PET in the Clinic | Neurodegenerative Diseases |  | | 2016 | 432 | 1 |
|
| MRI for Pre-Dementia Trials | The Journal of Prevention of Alzheimer's Disease |  | | 2016 | 338 | 0 |
|
| Assessment of the Incremental Diagnostic Value of Florbetapir F 18 Imaging in Patients With Cognitive Impairment: The Incremental Diagnostic Value of Amyloid PET With [18F]-Florbetapir (INDIA-FBP) Study | JAMA neurology |  | | 2016 | 494 | 2 |
|
| Automated hippocampal segmentation in 3D MRI using random undersampling with boosting algorithm | Pattern Analysis and Application |  | | 2016 | 418 | 231 |
|
| Occipital sources of resting-state alpha rhythms are related to local gray matter density in subjects with amnesic mild cognitive impairment and Alzheimer's disease | Neurobiology of Aging |  | | 2015 | 369 | 0 |
|
| Delphi definition of the EADC-ADNI Harmonized Protocol for hippocampal segmentation on magnetic resonance | Alzheimer's & dementia |  | | 2015 | 623 | 3 |
|
| Training labels for hippocampal segmentation based on the EADC-ADNI harmonized hippocampal protocol | Alzheimer's & dementia |  | | 2015 | 664 | 2 |
|
| The EADC-ADNI Harmonized Protocol for manual hippocampal segmentation on magnetic resonance: Evidence of validity | Alzheimer's & dementia |  | | 2015 | 642 | 2 |
|
| Hippocampal and amygdalar local structural differences in elderly patients with schizophrenia | The American journal of geriatric psychiatry |  | | 2015 | 520 | 0 |
|
| Relationship between hippocampal atrophy and neuropathology markers: a 7T MRI validation study of the EADC-ADNI Harmonized Hippocampal Segmentation Protocol | Alzheimer's & dementia |  | | 2015 | 576 | 3 |
|
| Harmonized benchmark labels of the hippocampus on magnetic resonance: The EADC-ADNI project | Alzheimer's & dementia |  | | 2015 | 647 | 1 |
|
| Manual segmentation qualification platform for the EADC-ADNI harmonized protocol for hippocampal segmentation project | Alzheimer's & dementia |  | | 2015 | 647 | 4 |
|
| Operationalizing protocol differences for EADC-ADNI manual hippocampal segmentation | Alzheimer's & dementia |  | | 2015 | 497 | 0 |
|
| Abnormalities in cortical gray matter density in borderline personality disorder | European psychiatry |  | | 2015 | 584 | 3 |
|
| Multiple RF classifier for the hippocampus segmentation: Method and validation on EADC-ADNI Harmonized Hippocampal Protocol | Physica Medica |  | | 2015 | 429 | 201 |
|
| Medial temporal atrophy in early and late-onset Alzheimer's disease | Neurobiology of aging |  | | 2014 | 534 | 2 |
|
| Impact of alcohol consumption in healthy adults: a magnetic resonance imaging investigation | Psychiatry Research |  | | 2014 | 402 | 0 |
|
| Establishing magnetic resonance images orientation for the EADC-ADNI manual hippocampal segmentation protocol | Journal of Neuroimaging |  | | 2014 | 422 | 0 |
|
| Coalition Against Major Diseases/European Medicines Agency biomarker qualification of hippocampal volume for enrichment of clinical trials in predementia stages of Alzheimer's disease | Alzheimer's & dementia |  | | 2014 | 538 | 1 |
|
| Atypical nucleus accumbens morphology in psychopathy: another limbic piece in the puzzle | International Journal of Law and Psychiatry |  | | 2013 | 367 | 0 |
|
| Structural brain features of borderline personality and bipolar disorders | Psychiatry Research |  | | 2013 | 451 | 0 |
|
| Striatal morphology in early-onset and late-onset Alzheimer's disease: a preliminary study | Neurobiology of Aging |  | | 2013 | 422 | 0 |
|
| Norms for imaging markers of brain reserve | Journal of Alzheimer's Disease |  | | 2012 | 440 | 0 |
|
| Volumetric and topographic differences in hippocampal subdivisions in borderline personality and bipolar disorders | Psychiatry research. Neuroimaging |  | | 2012 | 671 | 0 |
|
| Hippocampal and amygdalar volume changes in elderly patients with Alzheimer's disease and schizophrenia | Psychiatry research |  | | 2011 | 652 | 0 |
|
| Survey of protocols for the manual segmentation of the hippocampus: preparatory steps towards a joint EADC-ADNI harmonized protocol | Journal of Alzheimer's Disease |  | | 2011 | 422 | 0 |
|
| Cortex and amygdala morphology in psychopathy | Psychiatry Research |  | | 2011 | 568 | 1 |
|
| Local amygdala structural differences with 3T MRI in patients with Alzheimer disease | Neurology |  | | 2011 | 375 | 0 |
|
| The CST3 B haplotype is associated with frontotemporal lobar degeneration | European Journal of Neurology |  | | 2010 | 284 | 0 |
|
| Abnormal hippocampal shape in offenders with psychopathy | Human Brain Mapping |  | | 2010 | 368 | 0 |
|
| Clinical and medial temporal features in a family with mood disorders | Neuroscience Letters |  | | 2010 | 409 | 0 |
|
| H1 haplotype of the MAPT gene is associated with lower regional gray matter volume in healthy carriers | European Journal of Human Genetics |  | | 2009 | 402 | 0 |
|
| HOXA1 A218G polymorphism is associated with smaller cerebellar volume in healthy humans | Journal of Neuroimaging |  | | 2009 | 399 | 0 |
|
| White-matter lesions along the cholinergic tracts are related to cortical sources of EEG rhythms in amnesic mild cognitive impairment | Human Brain Mapping |  | | 2009 | 382 | 0 |
|
| Alexithymia in healthy women: a brain morphology study | Journal of Affective Disorders |  | | 2009 | 387 | 1 |
|
| The Italian Brain Normative Archive of structural MR scans: norms for medial temporal atrophy and white matter lesions | Aging Clinical and Experimental Research |  | | 2009 | 451 | 0 |
|
| Effect of the XbaI polymorphism of estrogen receptor alpha on postmenopausal gray matter | Neuroscience Letters |  | | 2008 | 389 | 0 |
|
| Hippocampal shape differences in dementia with Lewy bodies | NeuroImage |  | | 2008 | 330 | 0 |
|
| Effects of hormone therapy on brain morphology of healthy postmenopausal women: a Voxel-based morphometry study | Menopause |  | | 2006 | 404 | 1 |
|
| The effect of apolipoprotein polymorphism on brain in mild cognitive impairment: a voxel-based morphometric study | Dementia and Geriatric Cognitive Disorders |  | | 2006 | 456 | 0 |
|
| Topographic correspondence between white matter hyperintensities and brain atrophy | Journal of Neurology |  | | 2006 | 404 | 0 |
|
| Influence of serotonin receptor 2A His452Tyr polymorphism on brain temporal structures: a volumetric MR study | European Journal of Human Genetics |  | | 2006 | 394 | 0 |
|
| Cognitive rehabilitation for severe dementia: critical observations for better use of existing knowledge | Mechanisms of Ageing and Development |  | | 2006 | 365 | 0 |
|
| Effects of estrogens on cognition and brain morphology: involvement of the cerebellum | Maturitas |  | | 2006 | 413 | 0 |
|
| Frontotemporal dementia as a neural system disease | Neurobiology of Aging |  | | 2005 | 375 | 0 |
|
| APOE and modulation of Alzheimer's and frontotemporal dementia | Neuroscience Letters |  | | 2004 | 332 | 0 |
|
| The MRI pattern of frontal and temporal brain atrophy in fronto-temporal dementia | Neurobiology of Aging |  | | 2003 | 383 | 0 |
|
| Clinical characteristics of frontotemporal patients with symmetric brain atrophy | European Archives of Psychiatry and Clinical Neuroscience |  | | 2002 | 387 | 0 |
|
| Amygdaloid atrophy in frontotemporal dementia and Alzheimer's disease | Neuroscience Letters |  | | 2002 | 400 | 1 |
|